SC 13G
SC 13G Filing
- Company
- Solid Biosciences Inc.
- Filed
- September 1, 2022
- Accession Number
- 0001461790-22-000021
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →